Intended Use

LVivo platform is intended for non-invasive processing of ultrasound images to detect, measure, and calculate relevant medical parameters of structures and function of patients with suspected disease. It also provides Quality Score feedback.

Technology

The LVivo platform analyzes DICOM ultrasound movies using automated AI algorithms for global and segmental evaluation of the left ventricle by ejection fraction and strain, supports right ventricular function evaluation, and bladder volume measurement. It includes modules for contrast agent processing and various apical views, enabling automated frame selection, manual adjustments, and visualization of cardiac function.

Performance

Performance testing included evaluation on 101 patient exams across varied LV function levels. Automated results showed high correlation (r>0.93) with manual measurements by sonographers for end-diastolic volume, end-systolic volume, and ejection fraction across multiple apical views, demonstrating accuracy and reliability. 90% of exams were automatically processed successfully without need for cardiologist modification.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    10/10/2024

    4 months
  • 2

    FDA Approval

    3/3/2025

Other devices from DiA Imaging Analysis Ltd.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.